Navigation Links
Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
Date:8/28/2013

y Novel Drug Solutions of Randolph, New Jersey and Dr. Jeffrey T. Liegner of Sparta, New Jersey.  IPI-140 has been successfully administered by Dr. Liegner in more than 1,500 patients in his surgical practice.

Dr. Liegner stated, "The current treatment regimen for the prevention of post-cataract surgery complication is primarily a pre-operative and post-operative self-administered eye drop regimen, which requires from the patient strict compliance and careful adherence to a prescribed dosing schedule. Individuals with physical limitations, impaired manual dexterity, or those who lack of a supportive care giver, are particularly vulnerable to non-compliance and the subsequent complications of untreated post-surgical issues.  This uniquely designed drug, utilizing a fourth generation quinolone therapy combined with potent inflammatory suppression, when placed as a depot inside the vitreous concurrent with cataract surgery, or any intraocular procedure, addresses the primary ocular complications of ophthalmic surgery: infection risk and post-operative inflammation."

Imprimis believes that IPI140 may have broad application in ophthalmic surgery, including the $5 billion global cataract surgery drug market.  According to Ocular Surgery News, the cataract surgery market continues to grow tremendously not only because of the expanding aging population, but because the age at which patients demand cataract surgery has lowered, portending a global market size of $7-$9 billion in the next 5-7 years. 

Imprimis expects to continue to leverage its exclusive relationships with Novel Drug Solutions, Eye Care Northwest, and others to acquire assets with a proven clinical track record.

About Imprimis Pharmaceuticals, Inc.

Imprimis Pharmaceuticals, Inc. (NASDAQ:

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
2. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
3. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company
4. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
5. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
6. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
7. Imprimis Announces Key Leadership Appointments
8. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
9. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
10. Imprimis to Begin New Study of Its Topical Analgesic Drug
11. Imprimis Names Two Experts To Its Science And Regulatory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015 Sleep ... sleep therapy, and HGE Health Care Solutions, a ... announced today a comprehensive sleep management and cost ... (OSA). OSA is a chronic medical ... sleep and may increase a patient,s risk for ...
(Date:9/1/2015)... 1, 2015   Millstone Medical Outsourcing announced today ... in Olive Branch, MS. Now totaling ... facility has added the capacity required to meet the ... "This expansion gives us the opportunity to grow in parallel ... Millstone MS. "Two and a half years ago we were ...
(Date:9/1/2015)... Belgium , Sept. 1, 2015 VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... Executive Officer, Cameron Reynolds , is scheduled to attend ... is being held September 9-10, 2015 in Boston, ... on September 10. Wells Fargo Securities Research ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2Millstone Medical Outsourcing Announces Olive Branch Expansion 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4
... in Ohio supported by the biopharmaceutical research sector would ... new taxes in the Medicare prescription drug program – ... to technical work, manufacturing to construction and other building ... sector supports a broad array of high-quality jobs. ...
... Sept. 27, 2011 Visiting Nurse Services of ... home health agencies, announces that it has entered ... advanced home telehealth technology to patients with chronic ... Experts in Telehealth(SM), is a world class developer, ...
Cached Medicine Technology:Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies 3Visiting Nurse Services of Connecticut Selects Cardiocom® As Its New Telehealth Vendor 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... pleased to announce their partnership with Apex Physical Therapy (Apex) is ... continue to provide kind, compassionate, and empathetic care to local residents from their ...
(Date:9/1/2015)... Seattle, WA (PRWEB) , ... September 01, 2015 , ... ... despite increasing awareness of societal issues and needs. Money for Good 2015, released today ... for solving it. There’s an annual potential to mobilize up to $22B in new ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... options, Blue Cross and Blue Shield of Minnesota (Blue Cross) has announced Doctor ... , Based in San Francisco, Doctor On Demand provides immediate access to Board ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Cleveland Clinic, ranked a top-five hospital by U.S. News & World Report, to ... cancer patients. , Editorial and marketing groups within OncLive, which provides oncologists ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a ... announced today that it has hired Scott Sanderson, an experienced business development professional ... Sanderson will be responsible for establishing and managing new client relationships in the ...
Breaking Medicine News(10 mins):Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... A daily pinta or a helping of dairy foods protect ... metabolic syndrome , suggests a study in the Journal of ... linked to an increased risk of diabetes, coronary artery disease, ... of 2375 men aged between 45 and 59, all of ...
... molecule called 'P2X receptor' that control pain in humans ... development of painkillers for recurring migraine and backache. ... researchers including Dr Chris Thompson, Professor Alan North and ... ,Researchers examined slime moulds, microscopic amoeboid organisms to ...
... with the idea of shredding weight even at the age of ... her being fat made her follow a strict diet and exercise ... up if I had some fat," US Weekly quoted Duff, as ... control regime only when her sis Haylie intervened after she crashed ...
... (ER-alpha), is a risk factor for breast cancer development. ... . ,These ER-alphanegative cancers are more aggressive ... cancers, and have been thought to be estrogen independent. ... 12 in advance of publication in the August print ...
... year have eclipsed fatalities in 2006 as the country battles ... decade , medical officials said Thursday. ,Some 182 ... year out of 14,986 cases, said Ngan Chantha, director of ... reported. ,"The disease is continuing to spread, but ...
... Sciences has submitted an application with the Drug Controller ... clinical trials of its new drug Suvn-502 for treatment ... ,'Treatment for Alzheimer's disease and Schizophrenia is an ... discover drugs that address significant unmet medical needs,' said ...
Cached Medicine News:
... The CSV-1000CVA20/30 test face provides three contrast ... acuity from 20/16 to 20/100. This test is ... such as associated with contact lens evaluation or ... of the test provide the same contrast and ...
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
Contrast sensitivity testing, glare sensitivity testing and ETDRS acuity testing are provided in the self standardized CSV-1000 instrument. Patented photocell circuitry automatically monitors and cal...
... Sample of Topics Covered: diagrams, ... tx's and differentials of a ... eyes, vision loss, pupillary abnormalities, ... infections, medications, cataracts, vision correction ...
Medicine Products: